Photo: JEFF KOWALSKY / AFP / Getty Images
For: EFE Updated 17 May 2022 , 12: 02 pm EDT
The United States Food and Drug Administration (FDA) authorized this Tuesday the use of a booster dose of the Pfizer/BioNTech vaccine against COVID-19 for children between 5 and 11 years of age.
“While it is true that COVID-19 is usually less severe in children than in adults, the wave of Ómicron has caused more children to get sick and be hospitalized”, the commissioner of the FDA Robert M. Califf.
The doctor also reminded that some of these children may suffer long-term effects, even if they have not had very severe symptoms. severe when infected.
The authorization is based on a study of the immune response of a group of children which already allowed, in October 2021, the approval of the use of the complete guideline of the Pfizer vaccine for this age group.
At the beginning of the year, the FDA already authorized the booster dose for young people between 12 Y 15 year old.
Children under 5 years of age, however, still cannot be vaccinated against covid.
The country is about to exceed one million deaths by coronavirus: although Johns Hopkins University maintains the figure at 999,842, the US government already considered that number exceeded last Thursday.
“As a nation, we must not become insensitive to pain. To heal ourselves, we must remember”, said the president of the United States, Joe Biden.
It may interest you:
– COVID cases on the rise in Los Angeles with more than 4,000 in a day
– The pandemic is not over: the warning from the second global COVID summit
– Joe Biden regrets the “ tragic milestone” of one million deaths from COVID in the US